Announcing the 2022 Frank J. and Eleanor Maslowski Charitable Trust CHIP-CTO Fellow at the Center for Coronary Artery Disease

Complex High Risk Indicated Percutaneous Coronary Interventions (CHIP) - Chronic Total Occlusion (CTO) Fellowship
Sep 15, 2022
Image
Salman

The Center for Coronary Artery Disease at the Minneapolis Heart Institute Foundation® (MHIF) is dedicated to improving clinical practice and ultimately discovering life-saving treatments through innovative cardiovascular research. As part of the educational aim for the center, a one-year fellowship has been created to provide a robust experience to an individual interested in training in complex percutaneous coronary interventions and interventional cardiology research.

MHIF’s CCAD Science Center is delighted to welcome Salman Allana, MD, FACC, FSCAI, as the inaugural fellow of the Frank J. and Eleanor Maslowski Charitable Trust CHIP-CTO Fellowship Program starting July 1, 2022.

Dr. Allana joins us from the Medical College of Wisconsin, WI, where he was an Assistant Professor and Staff Interventional Cardiologist. He was also the Site Program Director for the Interventional Cardiology Fellowship Program at the Milwaukee VA Hospital. Between 2016 and 2019, Dr. Allana was an Interventional Cardiologist and Medical Director of the TAVR Program at Sentara Rockingham Memorial Hospital, Harrisonburg, VA.

Dr. Allana completed his medical school in Aga Khan University Hospital, Karachi, Pakistan, and subsequently moved to the United States and completed his Internal Medicine residency, Cardiovascular Disease fellowship and Interventional Cardiology fellowship at the University of Wisconsin Hospital and Clinics, Madison, WI. Throughout his medical training and practice, Dr. Allana has been actively involved in research, with presentations at the major cardiology congresses and peer-reviewed publications. Dr. Allana is Board Certified in Internal Medicine, Nuclear Cardiology, Cardiovascular Diseases and Interventional Cardiology.

The Center for Coronary Artery Disease at the Minneapolis Heart Institute Foundation is dedicated to improving clinical practice and ultimately discovering life-saving treatments through innovative cardiovascular research. The Frank J. and Eleanor Maslowski Charitable Trust CHIP-CTO Fellowship Program is a 1-year hybrid clinical and research training program for Interventional Cardiologists focused on specialized training in complex and high-risk percutaneous coronary interventions, including patient selection, procedural planning, use of advanced interventional techniques, and prevention and management of complications. The program also includes a clinical research focus on complex percutaneous coronary interventions and coronary artery disease.

The curriculum for the program consists of:

  • Chronic total occlusion (CTO) interventions
  • Advanced intravascular imaging and physiology
  • Bifurcations, thrombus management, treatment of acute coronary syndromes
  • Calcification and tortuosity
  • Hemodynamic support and treatment of cardiogenic shock
  • Complication prevention and management, radiation safety
  • Research in complex percutaneous coronary interventions and coronary artery disease

MHIF is strongly positioned for success with the Center for Coronary Artery Disease through its partnership with 70+ Minneapolis Heart Institute® cardiologists, who see more than 50,000 individual patients at nearly 57,000 clinic visits each year at Abbott Northwestern Hospital, which is consistently awarded with national rankings in cardiology and heart surgery by US News & World Reports.

Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.